Summary: S.2993 — 106th Congress (1999-2000)All Information (Except Text)

There is one summary for S.2993. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (07/27/2000)

Drug Competition Act of 2000 - Requires brand name drug manufacturers and generic drug manufacturers to file with the Federal Trade Commission and the Attorney General agreements affecting the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product.